Old Web
English
Sign In
Acemap
>
Paper
>
CTIM-27. PHASE I/II STUDY OF CONTROLLED IL-12 AS IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
CTIM-27. PHASE I/II STUDY OF CONTROLLED IL-12 AS IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
2020
Stewart Goldman
Sabine Mueller
Susan N. Chi
Amanda Saratsis
Rudy Allen
Jill Buck
Nathan Demars
Nira Hadar
Taylor Estupinan
John Miao
Erin Walsh
Arnold Gelb
Laurence Cooper
Keywords:
Immunotherapy
phase i ii
Cancer research
Chemistry
Interleukin 12
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]